One possibility, consistent with the greater potency of degrader molecules, is that protein interactions mediated by domains of BCL6 other than the BTB–POZ domain are required for maintenance of full proliferation in DLBCL cell lines, but it is not clear why inhibition of BTB–POZ function alone has so little effect. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.